French psychiatrists

Henri Legrand du Saulle (Dijon, 16 April 1830 – Paris, 5 May 1886) was a French psychiatrist.
As a young man he worked as an assistant to Bénédict Morel (1809–1873) at Saint-Yon, and also served under Louis-Florentin Calmeil (1798–1895) at the Charenton Asylum. In 1856 became a doctor to the medical faculty in Paris. Later on, he was appointed physician at the Bicêtre Hospital (replacing Prosper Lucas 1805–1885), and in 1879 succeeded Louis Delasiauve (1804–1893) as chief physician in the department for epileptics at Salpêtrière Hospital. During his career he was also associated with the Prefecture of Police, serving from 1863 as médecin-adjoint to Charles Lasègue (1816–1883).He is known for his studies on personality disorders, particularly pioneer work involving phobias and obsessive-compulsive disorders. He also performed extensive work in forensic psychiatry, being interested with the medical-judicial aspects of psychopathology.

Alix Joffroy (16 December 1844, in Stainville – 24 November 1908) was a French neurologist and psychiatrist remembered for describing Joffroy's sign. He studied in Paris, earning his doctorate in 1873, becoming médecin des hôpitaux in 1879 and agrégé in 1880. He worked at the Pitié-Salpêtrière Hospital from 1885 and succeeded Benjamin Ball as professor of clinical psychiatry in 1893.
Jean-Martin Charcot encouraged him to study neurology, and together they demonstrated atrophy of anterior horn cells in the spinal cord in poliomyelitis in 1869.

Adrien Alphonse Alcide Borel (19 March 1886, in Paris – 19 September 1966, in Beaumont-lès-Valence) was a French psychiatrist and psychoanalyst.

Joseph Louis Irenée Jean Abadie (15 December 1873, Tarbes – 1934) was a French neurologist who is remembered for naming Abadie's symptom.

David Servan-Schreiber (April 21, 1961 – July 24, 2011) was a French physician, neuroscientist and author. He was a clinical professor of psychiatry at the University of Pittsburgh School of Medicine. He was also a lecturer in the Faculty of Medicine of Université Claude Bernard Lyon 1.

Pierre Deniker (16 February 1917, in Paris – 17 August 1998) was involved, jointly with Jean Delay and J. M. Harl, in the introduction of chlorpromazine (Thorazine), the first antipsychotic used in the treatment of schizophrenia, in the 1950s. Thorazine had been used in surgical procedures peri-operatively as an anti-nausea medication in France. Patients were noted to be less anxious and calmer. This observation eventually led Deniker to try chlorpromazine with patients who had schizophrenia, where he observed notable improvement in symptoms.
The pharmaceutical company Smith-Kline had purchased the chlorpromazine rights from Rhone-Poulenc in France and had been marketing it as an anti-nausea medication. After Deniker's observations, they sought and received FDA approval in 1954 to market Thorazine for the treatment of schizophrenia.

Édouard Toulouse (10 December 1865 in Marseille – 19 January 1947 in Paris) was a French psychiatrist, journalist, and director of the literary magazine Demain.

Dominique-Octave Mannoni (French: [manoni]; 29 August 1899, in Sologne – 30 July 1989, in Paris) was a French psychoanalyst and author.

Valentin Magnan (16 March 1835 – 27 September 1916) was a French psychiatrist active in the 19th century.

Ernest-Charles Lasègue (5 September 1816 – 20 March 1883) was a French physician that released over one hundred scientific papers. He became recognized in the mid-19th century from his work in the fields of psychiatry and neurology. He published many of his works in a journal called Archives Générales de Médecine (Archives of General Medicine), in which he was an editor. A few of his major contributions consisted of his work with delusions of persecutions, a concept coined "folie à deux," and his description of hysterical anorexia. Aside from his publications, he worked various jobs before becoming the Chair of Clinical Medicine at Pitié-Salpêtrière Hospital. He remained positioned there until dying at the age of 66 due to complications from diabetes.